LOU064, -, -, Placebo to LOU064 Film-coated tablet
CLOU064M12101
Phase 2 small_molecule active
Quick answer
LOU064, -, -, Placebo to LOU064 Film-coated tablet for Chronic Inducible urticaria and Chronic Spontaneous Urticaria is a Phase 2 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- Chronic Inducible urticaria and Chronic Spontaneous Urticaria
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active